Publication | Open Access

Safety and efficacy of PD-1 blockade-activated multiple antigen-specific cellular therapy alone or in combination with apatinib in patients with advanced solid tumors: a pooled analysis of two prospective trials

Tumor ImmunologyCancer ImmunosurveillanceMedicineImmunologyAdvanced Solid TumorsImmune Checkpoint InhibitorProspective TrialsCancer TreatmentPooled AnalysisImmunotherapyOncologyRadiation Oncology